-
RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection
drugs
May 17, 2019
RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection.
-
FDA: Tattoo Inks Recalled Due to Bacterial Contamination
drugs
May 16, 2019
Six tattoo inks have been recalled because they are contaminated with bacteria and could lead to infection that poses a serious health risk, the U.S. Food and Drug Administration says.
-
Nabriva hit with FDA rejection of Contempo for complicated urinary tract infections
pharmatimes
May 10, 2019
Nabriva hit with FDA rejection of Contempo for complicated urinary tract infections.
-
Hepatitis A Infections Soaring: CDC
drugs
May 10, 2019
Hepatitis A Infections Soaring: CDC.
-
CDC: HIV Racial Disparity Measure Decreased From 2010 to 2016
drugs
May 10, 2019
CDC: HIV Racial Disparity Measure Decreased From 2010 to 2016.
-
Biktarvy approved for the treatment of HIV-1 infection
europeanpharmaceuticalreview
April 29, 2019
Biktarvy approved for the treatment of HIV-1 infection
-
New research could spot people most susceptible to infection after knee replacement surgery
biospectrumasia
April 25, 2019
New research funded by the National Institute for Health Research (NIHR) has identified which groups of people are most likely to develop a severe infection after knee replacement surgery and therefore need the joint replacement redone.
-
Largest oral HPV study in England shows lower rates of infection
europeanpharmaceuticalreview
April 22, 2019
The study found that lifestyle factors are incredibly important in preventing infection from HR-HPV, with tobacco usage being a risk factor…
-
FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection
drugs
April 17, 2019
FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection.
-
Nationalised drug firms may address superbug threat, says Jim O’Neill
pharmaceutical-technology
April 11, 2019
Nationalised drug firms may address superbug threat, says Jim O’Neill.